Outbreak-Causing Fungi: Pneumocystis jirovecii
- PMID: 31782069
- DOI: 10.1007/s11046-019-00408-w
Outbreak-Causing Fungi: Pneumocystis jirovecii
Abstract
Pneumocystis jirovecii pneumonia (PCP) is an important cause of morbidity in immunocompromised patients, with a higher mortality in non-HIV than in HIV patients. P. jirovecii is one of the rare transmissible pathogenic fungi and the only one that depends fully on the host to survive and proliferate. Transmissibility among humans is one of the main specificities of P. jirovecii. Hence, the description of multiple outbreaks raises questions regarding preventive care management of the disease, especially in the non-HIV population. Indeed, chemoprophylaxis is well codified in HIV patients but there is a trend for modifications of the recommendations in the non-HIV population. In this review, we aim to discuss the mode of transmission of P. jirovecii, identify published outbreaks of PCP and describe molecular tools available to study these outbreaks. Finally, we discuss public health and infection control implications of PCP outbreaks in hospital setting for in- and outpatients.
Keywords: Infection control; Invasive fungal disease; Molecular typing; Outbreaks; Pneumocystis; Renal transplant recipient.
Similar articles
-
Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control.J Hosp Infect. 2016 May;93(1):1-8. doi: 10.1016/j.jhin.2016.01.018. Epub 2016 Feb 10. J Hosp Infect. 2016. PMID: 26996089 Review.
-
A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection.Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2429-37. doi: 10.1007/s10096-012-1586-x. Epub 2012 Mar 9. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22402816
-
Healthcare related transmission of Pneumocystis pneumonia: From key insights toward comprehensive prevention.Transpl Infect Dis. 2018 Oct;20(5):e12942. doi: 10.1111/tid.12942. Epub 2018 Jun 28. Transpl Infect Dis. 2018. PMID: 29873156 Review.
-
Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission.Clin Infect Dis. 2017 Oct 1;65(7):1120-1126. doi: 10.1093/cid/cix495. Clin Infect Dis. 2017. PMID: 28549105
-
Investigation of outbreaks of Pneumocystis jirovecii pneumonia in two Scottish renal units.J Hosp Infect. 2017 Jun;96(2):151-156. doi: 10.1016/j.jhin.2016.11.005. Epub 2016 Nov 18. J Hosp Infect. 2017. PMID: 28169011
Cited by
-
The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models.J Fungi (Basel). 2021 Sep 11;7(9):747. doi: 10.3390/jof7090747. J Fungi (Basel). 2021. PMID: 34575785 Free PMC article.
-
Short Tandem Repeat Genotyping of Medically Important Fungi: A Comprehensive Review of a Powerful Tool with Extensive Future Potential.Mycopathologia. 2024 Aug 3;189(5):72. doi: 10.1007/s11046-024-00877-8. Mycopathologia. 2024. PMID: 39096450 Free PMC article. Review.
-
Global prevalence, mortality, and main characteristics of HIV-associated pneumocystosis: A systematic review and meta-analysis.PLoS One. 2024 Mar 25;19(3):e0297619. doi: 10.1371/journal.pone.0297619. eCollection 2024. PLoS One. 2024. PMID: 38526997 Free PMC article.
-
Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection.J Fungi (Basel). 2023 Jul 31;9(8):812. doi: 10.3390/jof9080812. J Fungi (Basel). 2023. PMID: 37623583 Free PMC article. Review.
-
Risk factors for identifying pneumocystis pneumonia in pediatric patients.Front Cell Infect Microbiol. 2024 Oct 23;14:1398152. doi: 10.3389/fcimb.2024.1398152. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39507946 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources